PT1515741E - Utilização de hidrolisado de colagénio para reduzir a viscosidade de uma composição compreendendo goma de guar - Google Patents

Utilização de hidrolisado de colagénio para reduzir a viscosidade de uma composição compreendendo goma de guar Download PDF

Info

Publication number
PT1515741E
PT1515741E PT03759947T PT03759947T PT1515741E PT 1515741 E PT1515741 E PT 1515741E PT 03759947 T PT03759947 T PT 03759947T PT 03759947 T PT03759947 T PT 03759947T PT 1515741 E PT1515741 E PT 1515741E
Authority
PT
Portugal
Prior art keywords
viscosity
composition
guar gum
collagen hydrolysate
lowering
Prior art date
Application number
PT03759947T
Other languages
English (en)
Inventor
Nicolas Auriou
Michael Beer
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PT1515741E publication Critical patent/PT1515741E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
PT03759947T 2002-06-13 2003-06-12 Utilização de hidrolisado de colagénio para reduzir a viscosidade de uma composição compreendendo goma de guar PT1515741E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0213612.5A GB0213612D0 (en) 2002-06-13 2002-06-13 Organic compounds

Publications (1)

Publication Number Publication Date
PT1515741E true PT1515741E (pt) 2011-06-30

Family

ID=9938524

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03759947T PT1515741E (pt) 2002-06-13 2003-06-12 Utilização de hidrolisado de colagénio para reduzir a viscosidade de uma composição compreendendo goma de guar

Country Status (14)

Country Link
US (1) US20060099324A1 (pt)
EP (1) EP1515741B1 (pt)
JP (2) JP2005534667A (pt)
AT (1) ATE502644T1 (pt)
AU (1) AU2003242692C1 (pt)
CA (1) CA2489250C (pt)
DE (1) DE60336472D1 (pt)
DK (1) DK1515741T3 (pt)
ES (1) ES2363220T3 (pt)
GB (1) GB0213612D0 (pt)
HK (1) HK1075012A1 (pt)
PT (1) PT1515741E (pt)
WO (1) WO2003105882A1 (pt)
ZA (1) ZA200409528B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10331202A1 (de) * 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
EP1681937A4 (en) 2003-10-16 2012-01-04 Techcom Group Llc FOOD WITH REDUCED DIGESTIBLE CARBOHYDRATE CONTENT WITH REDUCED GLYCEMIC RESPONSE
US8227008B1 (en) * 2003-10-22 2012-07-24 Cybersoft, Inc. Low carbohydrate, functional-like foods and systems incorporating same
US7879380B1 (en) * 2003-10-22 2011-02-01 Cybersoft, Inc. Apparatus, methods and articles of manufacture for high conductivity cooking
KR20070034528A (ko) * 2004-05-27 2007-03-28 캄피나 네덜란드 홀딩 베.붸. Ｄｐｐ－ｉｖ 매개 질병의 예방 및／또는 치료용 의약품제조를 위한 단백질 가수분해물의 용도
ES2700463T3 (es) * 2004-07-19 2019-02-15 Nutricia Nv Uso de aspartato para regular los niveles de glucosa en sangre
US20060105021A1 (en) * 2004-09-24 2006-05-18 Remington Direct Lp Cholesterol-reducing liquid
EP1811859B1 (en) * 2004-11-19 2016-05-04 DSM IP Assets B.V. Modified plant gums for powderous preparations of active ingredients
ATE542896T1 (de) 2004-12-23 2012-02-15 Campina Nederland Holding Bv Mit dpp-iv hemmenden peptiden angereichertes proteinhydrolysat und deren verwendung
TW200803751A (en) 2005-11-30 2008-01-16 Campina Nederland Holding Bv Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1
DE102006036285A1 (de) 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
FI122915B (fi) * 2006-09-06 2012-08-31 Cerefi Oy Kylläisyyttä aiheuttava tuote
IN2014DN03102A (pt) 2006-11-07 2015-07-10 Procter & Gamble
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
FR2912607B1 (fr) * 2007-02-20 2009-10-02 Gervais Danone Sa Produit alimentaire semi-fluide comprenant des fibres de beta-glucane et de la gomme de guar, utilisation en tant qu'aliment fonctionnel
JP2010018522A (ja) * 2007-03-23 2010-01-28 Hiroshima Univ アディポネクチン産生促進剤
US8518469B2 (en) * 2007-06-12 2013-08-27 Kraft Foods Group Brands Llc Powdered beverage composition
FR2917948B1 (fr) * 2007-06-29 2010-10-29 Gervais Danone Sa Preparation de fruits stable a forte concentration de gomme d'acacia
JP5456246B2 (ja) * 2007-09-19 2014-03-26 太陽化学株式会社 腹持ち向上食品及びペットフード
WO2011053786A2 (en) * 2009-10-31 2011-05-05 Solae, Llc Gluten free structured protein product
WO2011112074A1 (en) * 2010-03-11 2011-09-15 N.V. Nutricia Novel glucose tolerance test and composition for use
US9034342B2 (en) * 2010-03-25 2015-05-19 Gateway Health Alliances, Inc Methods and compositions to reduce fat gain, promote weight loss in animals
US8679551B2 (en) * 2010-04-12 2014-03-25 Esm Holdings, Llc Methods for treating glucose metabolic disorders
EP2448432A1 (en) * 2010-08-17 2012-05-09 Abbott Laboratories Nutritional composition comprising cereal beta-glucan and salacia extract
AU2013204801B2 (en) * 2012-05-23 2014-11-06 Omniblend Innovation Pty Ltd Composition and method for management of diabetes or pre-diabetes
EP2700321A1 (en) * 2012-08-24 2014-02-26 Etablissements J. Soufflet Aqueous food composition enriched in beta-glucan
TW201501653A (zh) * 2013-03-07 2015-01-16 Otsuka Pharma Co Ltd 含大麥粉末之食品
JP5794373B1 (ja) * 2014-10-28 2015-10-14 不二製油株式会社 肉様食感の強い組織状大豆蛋白質素材
WO2015190142A1 (ja) * 2014-06-10 2015-12-17 不二製油グループ本社株式会社 肉様食感の強い組織状大豆蛋白質素材
CN105341561A (zh) * 2014-08-18 2016-02-24 塔特和莱利瑞典公司 具有改善口感的降脂肪组合物
CA2959350A1 (en) * 2014-08-27 2016-03-03 Fmc Corporation Improved drink stabilizer composition and stabilized drink compositions
JP5746414B1 (ja) * 2014-11-25 2015-07-08 森永製菓株式会社 麺様ゲル状食品用の麺線付着防止剤及び麺様ゲル状食品
UA121122C2 (uk) * 2014-11-26 2020-04-10 Омега Фарма Інновейшн Енд Девелопмент Нв Композиція харчових волокон
KR101525948B1 (ko) * 2014-12-10 2015-06-05 주식회사 엔에스웰니스 캐롭 추출물을 유효성분으로 포함하는 남성 갱년기 예방 및 개선용 조성물
CN105982038A (zh) * 2015-02-09 2016-10-05 可口可乐公司 用于再造粒的组合物和方法
JP2016154461A (ja) * 2015-02-23 2016-09-01 味の素ゼネラルフーヅ株式会社 粉末状組成物及びスムージー様飲料
US10226063B2 (en) * 2015-10-01 2019-03-12 The United States Of America As Represented By The Secretary Of Agriculture Methods of decreasing the viscosity of a dietary fiber
EP3167895A1 (en) * 2015-11-10 2017-05-17 University College Dublin A dietary supplement comprising beta-glucan and casein hydrolysate for improving health and growth performance in a mammal
ITUA20163937A1 (it) * 2016-05-30 2017-11-30 Pharcoterm S R L Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso.
WO2023218417A1 (en) * 2022-05-12 2023-11-16 The Live Green Group, Inc., Plant-only gums (3) replacement system in food products and methods of preparation thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3889007A (en) * 1973-01-26 1975-06-10 Ocean Food Inc Aquatic animal food composition
GB2021948A (en) * 1978-05-30 1979-12-12 Speywood Lab Ltd Water miscible gum composition and its preparation and use
ZA793769B (en) * 1978-07-25 1981-02-25 Wellcome Found Pharmaceutical formulation of guar gum
JPS56169560A (en) * 1980-05-30 1981-12-26 Tanpei Seiyaku Kk Dietary food
US4478658A (en) * 1982-12-20 1984-10-23 Warner-Lambert Company Method for sealing non-enteric capsules
JPS63185339A (ja) * 1986-09-01 1988-07-30 Terumo Corp 食品用組成物
US5126332A (en) * 1986-09-01 1992-06-30 Terumo Kabushiki Kaisha Food compositions for the prevention of overeating
AU651626B2 (en) * 1990-10-24 1994-07-28 Nestec S.A. Medical foods having soluble fiber
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5545411A (en) * 1994-12-16 1996-08-13 Bristol-Myers Squibb Company Method for lowering viscosity by use of gum acacia
JPH104876A (ja) * 1996-06-19 1998-01-13 Calpis Food Ind Co Ltd:The カルシウム入り乳性酸性飲料
JP3720496B2 (ja) * 1996-11-29 2005-11-30 ユニテックフーズ株式会社 新規ペクチン及びそれを含有する乳化液
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
WO1998039980A1 (en) * 1997-03-13 1998-09-17 Abbott Laboratories Nutritional formula containing hydrolyzed protein and a fiber blend
CN1108149C (zh) * 1997-03-18 2003-05-14 新时代株式会社 固体微粒形成用组合物
ATE362715T1 (de) * 1997-06-23 2007-06-15 Nestle Sa Zusammensetzung zur ernährung von diabetikern
EP0887024B1 (fr) * 1997-06-23 2004-05-26 Societe Des Produits Nestle S.A. Composition nutritive comprenant fibres de pois et inuline
CA2252691C (en) * 1997-11-07 2005-12-06 Kyowa Hakko Kogyo Co., Ltd. Protein-containing acidic foods and drinks
US6210686B1 (en) * 1998-12-18 2001-04-03 Beth Israel Deaconess Medical Center Dietary supplement and method for lowering risk of heart disease
US6355609B1 (en) * 1999-04-14 2002-03-12 Nestec S.A. Methods for stabilizing liquid nutritional products and products so stabilized
JP4620819B2 (ja) * 1999-08-25 2011-01-26 味の素株式会社 高カロリー高蛋白質流動食
JP2001120227A (ja) * 1999-10-29 2001-05-08 We'll Corporation:Kk ダイエット食品
JP2003517018A (ja) * 1999-12-16 2003-05-20 シスキンド，ハリー 栄養組成物、該組成物を製造する方法、及び該組成物を使用する方法
JP3907098B2 (ja) * 2001-02-13 2007-04-18 株式会社大塚製薬工場 栄養飲料またはゼリー

Also Published As

Publication number Publication date
CA2489250C (en) 2013-12-10
ZA200409528B (en) 2006-01-25
DE60336472D1 (de) 2011-05-05
ATE502644T1 (de) 2011-04-15
ES2363220T3 (es) 2011-07-27
AU2003242692C1 (en) 2009-06-04
JP2010254702A (ja) 2010-11-11
JP2005534667A (ja) 2005-11-17
EP1515741B1 (en) 2011-03-23
DK1515741T3 (da) 2011-07-11
WO2003105882A1 (en) 2003-12-24
US20060099324A1 (en) 2006-05-11
GB0213612D0 (en) 2002-07-24
HK1075012A1 (en) 2005-12-02
AU2003242692A1 (en) 2003-12-31
CA2489250A1 (en) 2003-12-24
EP1515741A1 (en) 2005-03-23

Similar Documents

Publication Publication Date Title
HK1075012A1 (en) Use of collagen hydrolysate to lower the viscosity of a composition comprising guar gum
MX337422B (es) Composiciones y metodos para incrementar la sencibilidad a la insulina.
PT1061900E (pt) Composicoes e metodos para libertacao de uma droga
LU92273I9 (pt)
EP1196444B8 (en) Exendin-4 conjugates and their medical use
DE602006008985D1 (de) Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund
NZ515902A (en) Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, and type 2 diabetes
MXPA03000190A (es) Composicion para el suministro del factor de crecimiento hamtopoyetico.
TNSN03116A1 (en) Pulmonary administration of chemically modified insulin
ATE446776T1 (de) Zusammensetzung zur gefässbeschichtung
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
MXPA05012564A (es) Dispositivo de tratamiento oral que incluyen una capa de barrera flexible, delgada y un tratamiento de endoesqueleto o composicion adhesiva.
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
HK1042496A1 (en) Novel heteroaromatic inhibitors of fructose 1,6-bishosphatase
PT1349856E (pt) Compostos de isoindolina-1-ona activadores da glicocinase
ATE362715T1 (de) Zusammensetzung zur ernährung von diabetikern
WO2009029049A8 (en) A bone and/or dental cement composition and uses thereof
TR200002869T2 (tr) İkame edilmiş indolealkonik asitler.
WO2004069181A3 (en) Composition for the treatment of intraocular pressure
TW200633696A (en) Sesamin/episesamin compositions
DE69402951T2 (de) Kombinierten Polymere zur Verwendung in künstlicher Tränenflussigkeit
EP1683528A4 (en) POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM
TW200733897A (en) Oral product for moistening skin
BR9916858A (pt) ((aminoiminometil)amino)alcanocarboxamidas e asaplicações das mesmas em terapia
Nicholson Emerging ethical issues in restorative dentistry